SMITHS Grp PLC/S (SMGZY) Rating Lowered to Underperform at Royal Bank of Canada
SMGZY has been the subject of a number of other research reports. JPMorgan Chase & Co. reaffirmed a neutral rating on shares of SMITHS Grp PLC/S in a research report on Friday, September 21st. Goldman Sachs Group reaffirmed a neutral rating on shares of SMITHS Grp PLC/S in a research report on Thursday, October 4th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. SMITHS Grp PLC/S presently has a consensus rating of Hold and a consensus price target of $27.00.
Shares of SMGZY stock opened at $17.66 on Tuesday. SMITHS Grp PLC/S has a 1-year low of $16.26 and a 1-year high of $24.42. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.56 and a current ratio of 2.04.
Smiths Group plc operates as a technology company severing the medical technology, security and defense, general industrial, oil and gas, and space and commercial aerospace markets worldwide. The company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek.
Receive News & Ratings for SMITHS Grp PLC/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SMITHS Grp PLC/S and related companies with MarketBeat.com's FREE daily email newsletter.